![An Embedded Fragment Method for Molecules in Strong Magnetic Fields | Journal of Chemical Theory and Computation An Embedded Fragment Method for Molecules in Strong Magnetic Fields | Journal of Chemical Theory and Computation](https://pubs.acs.org/cms/10.1021/acs.jctc.2c00865/asset/images/large/ct2c00865_0008.jpeg)
An Embedded Fragment Method for Molecules in Strong Magnetic Fields | Journal of Chemical Theory and Computation
![Rolf HESSELMANN | Radiopharmaceuticals Senior Expert (Clinical Studies, Market Authorisations, Special Approvals) | Dr. sc. ETH | Bundesamt für Gesundheit, Schweiz, Bern | BAG | Strahlenschutz Sektion Forschung & Nuklearmedizin | Research profile Rolf HESSELMANN | Radiopharmaceuticals Senior Expert (Clinical Studies, Market Authorisations, Special Approvals) | Dr. sc. ETH | Bundesamt für Gesundheit, Schweiz, Bern | BAG | Strahlenschutz Sektion Forschung & Nuklearmedizin | Research profile](https://www.researchgate.net/profile/Rolf-Hesselmann/publication/49654817/figure/fig3/AS:394359485812739@1471034036140/year-old-female-patient-34-months-postoperatively-with-no-increased-uptake-around_Q320.jpg)
Rolf HESSELMANN | Radiopharmaceuticals Senior Expert (Clinical Studies, Market Authorisations, Special Approvals) | Dr. sc. ETH | Bundesamt für Gesundheit, Schweiz, Bern | BAG | Strahlenschutz Sektion Forschung & Nuklearmedizin | Research profile
![Rolf HESSELMANN | Radiopharmaceuticals Senior Expert (Clinical Studies, Market Authorisations, Special Approvals) | Dr. sc. ETH | Bundesamt für Gesundheit, Schweiz, Bern | BAG | Strahlenschutz Sektion Forschung & Nuklearmedizin | Research profile Rolf HESSELMANN | Radiopharmaceuticals Senior Expert (Clinical Studies, Market Authorisations, Special Approvals) | Dr. sc. ETH | Bundesamt für Gesundheit, Schweiz, Bern | BAG | Strahlenschutz Sektion Forschung & Nuklearmedizin | Research profile](https://www.researchgate.net/profile/Rolf-Hesselmann/publication/49654817/figure/fig1/AS:394359485812737@1471034036027/year-old-female-patient-92-months-postoperatively-with-the-lowest-of-three-cervical_Q320.jpg)
Rolf HESSELMANN | Radiopharmaceuticals Senior Expert (Clinical Studies, Market Authorisations, Special Approvals) | Dr. sc. ETH | Bundesamt für Gesundheit, Schweiz, Bern | BAG | Strahlenschutz Sektion Forschung & Nuklearmedizin | Research profile
![Rolf HESSELMANN | Radiopharmaceuticals Senior Expert (Clinical Studies, Market Authorisations, Special Approvals) | Dr. sc. ETH | Bundesamt für Gesundheit, Schweiz, Bern | BAG | Strahlenschutz Sektion Forschung & Nuklearmedizin | Research profile Rolf HESSELMANN | Radiopharmaceuticals Senior Expert (Clinical Studies, Market Authorisations, Special Approvals) | Dr. sc. ETH | Bundesamt für Gesundheit, Schweiz, Bern | BAG | Strahlenschutz Sektion Forschung & Nuklearmedizin | Research profile](https://www.researchgate.net/profile/Rolf-Hesselmann/publication/49654817/figure/fig4/AS:394359485812742@1471034036529/year-old-female-patient-102-and-35-months-postoperatively-with-no-increased-uptake_Q320.jpg)
Rolf HESSELMANN | Radiopharmaceuticals Senior Expert (Clinical Studies, Market Authorisations, Special Approvals) | Dr. sc. ETH | Bundesamt für Gesundheit, Schweiz, Bern | BAG | Strahlenschutz Sektion Forschung & Nuklearmedizin | Research profile
![New Mechanistic Pathways for the Reactions of Formaldehyde with Formic Acid Catalyzed by Sulfuric Acid and Formaldehyde with Sulfuric Acid Catalyzed by Formic Acid: Formation of Potential Secondary Organic Aerosol Precursors New Mechanistic Pathways for the Reactions of Formaldehyde with Formic Acid Catalyzed by Sulfuric Acid and Formaldehyde with Sulfuric Acid Catalyzed by Formic Acid: Formation of Potential Secondary Organic Aerosol Precursors](https://pubs.acs.org/cms/10.1021/acsearthspacechem.1c00002/asset/images/medium/sp1c00002_0007.gif)
New Mechanistic Pathways for the Reactions of Formaldehyde with Formic Acid Catalyzed by Sulfuric Acid and Formaldehyde with Sulfuric Acid Catalyzed by Formic Acid: Formation of Potential Secondary Organic Aerosol Precursors
Strahlenschutz und Überwachung der Radioaktivität in der Schweiz Ergebnisse 2015 Radioprotection et surveillance de la radioa
![An Embedded Fragment Method for Molecules in Strong Magnetic Fields | Journal of Chemical Theory and Computation An Embedded Fragment Method for Molecules in Strong Magnetic Fields | Journal of Chemical Theory and Computation](https://pubs.acs.org/cms/10.1021/acs.jctc.2c00865/asset/images/large/ct2c00865_0005.jpeg)
An Embedded Fragment Method for Molecules in Strong Magnetic Fields | Journal of Chemical Theory and Computation
![An Embedded Fragment Method for Molecules in Strong Magnetic Fields | Journal of Chemical Theory and Computation An Embedded Fragment Method for Molecules in Strong Magnetic Fields | Journal of Chemical Theory and Computation](https://pubs.acs.org/cms/10.1021/acs.jctc.2c00865/asset/images/large/ct2c00865_0007.jpeg)
An Embedded Fragment Method for Molecules in Strong Magnetic Fields | Journal of Chemical Theory and Computation
![Rolf HESSELMANN | Radiopharmaceuticals Senior Expert (Clinical Studies, Market Authorisations, Special Approvals) | Dr. sc. ETH | Bundesamt für Gesundheit, Schweiz, Bern | BAG | Strahlenschutz Sektion Forschung & Nuklearmedizin | Research profile Rolf HESSELMANN | Radiopharmaceuticals Senior Expert (Clinical Studies, Market Authorisations, Special Approvals) | Dr. sc. ETH | Bundesamt für Gesundheit, Schweiz, Bern | BAG | Strahlenschutz Sektion Forschung & Nuklearmedizin | Research profile](https://i1.rgstatic.net/ii/profile.image/272409982926896-1441959010067_Q128/Damian-Wild.jpg)